|
|
Article: Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study.(Research)(Clinical report)
- Article from:
- Critical Care
- Article date:
- May 2, 2008
- Author:
CopyrightCOPYRIGHT 2008 BioMed Central Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Authors: Saad Nseir (corresponding author) [1,2]; Rapha
ël Favory [1]; Elsa Jozefowicz [3]; Franck Decamps [4]; Florent Dewavrin [5]; Guillaume Brunin [6]; Christophe Di Pompeo [2]; Daniel Mathieu [1]; Alain Durocher [1,2]
Introduction
Ventilator-associated tracheobronchitis (VAT) is common among mechanically ventilated critically ill patients [1, 2, 3]. Previous studies found VAT to be associated with increased duration of mechanical ventilation and intensive care unit (ICU) stay [1, 4, 5]. VAT is probably an intermediate process between lower respiratory tract colonization and ventilator-associated pneumonia (VAP). Postmortem studies ...
Related newspaper, magazine, and journal articles:
|
|
Article: Zep Manufacturing Co. (IPE Preview).(develops ...
The National Provisioner;
December 1, 2002 ;
700+ words
...Zep Manufacturing Co. has developed the Zep Antimicrobial Treatment System (ZATS) for online processing of pre-chilled carcasses contaminated during evisceration with digestive tract contents ...
|
|